Register today for the 2024 Cancer Retreat Secure my ticket 9 am – Session 1: Plenary In the plenary session, the event will address learnings from the National Training Day, and the outcomes from the 2024 CTI Board Strategy Day, including the priorities agreed. One of our confirmed speakers will be a major funder of CTI, and we also aim to feature a presentation on a recent submission for PEACEPLUS funding (All-Island initiative).   10am – Session 2: Workshop – Learnings from the HRB grant (CTI members only) Preparations are already beginning for the next HRB Grant cycle, so we ..read more

This year’s theme for the Retreat is “Securing Our Futures”. The agenda is being finalised, and while many of the individual contributors are currently being confirmed we can at this point outline the shape of the event. We hope that you have already marked the date in your calendar, and we encourage you to attend the event (in RCSI, Dublin) if at all possible. The Retreat is run for the benefit of all CTI members and your participation is essential. Session 1: Plenary In the plenary session, the event will address learnings from the National Training Day, and the outcomes from the 2024 CT ..read more

Every quarter, Cancer Trials Ireland features a recent Journal Publication, including a short note on the study’s importance from an author.  Prof Janice Walshe, Consultant Medical Oncologist The POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for women with endocrine responsIVE breast cancer) clinical trial allows women with breast cancer to pause their treatment to try to become pregnant. Question: Is it safe for young women with hormone-sensitive breast cancer to temporarily interrupt their endocrine treatment to permit pregnancy? The answer is a resounding yes. Backgrou ..read more

The Annual Review for 2022 has been published and is available for review by clicking on the image (right). The 2022 review includes:  Messages from Chair, CEO & Clinical Lead Summary of key ‘at a glance’ figures for the year Achievements & Performance for 2022  Metrics for 2022, including accruals, audits, collaborations and more.  Please note that the Director’s Report for 2022 (i.e. the Auditor’s full report) is available in the governance section of our website here.  ..read more

Aspects of Next Generation Sequencing in Oncology: Liquid Biopsies and Variant Interpretation Register here (click) The Molecular Tumour Board will host a Live Webinar Workshop session on the 10th October 2023, 16.00-17.00. This promises to be highly informative educational meeting delivered by the resident experts of the Molecular Tumour Board as they set out to explain the practicalities and considerations around NGS testing. To register a place at this event email: MTB@cancertrials.ie CPD Approval: This event is allocated 1 CPD credit in the External CPD category by RCPI. This CPD Re ..read more

The 2023 Spring DSSGs take place on Friday, March 31st 2023.  The agenda for the day is at the foot of this page, if you are a member of Cancer Trials Ireland you will receive an email this week (commencing Mar 27th) that includes an Agenda with all MS Teams links included.  Attending in person? You must be registered to attend in person – email info@cancertrials.ie to register. The Stakeholder Meeting is open to non-members, but DSSG meetings may only be attended by Cancer Trials Ireland members.  Where to go:  Tercentenary Hall, 2nd Floor, TCD Biomedical Sciences ..read more

A Guide to Next Generation Sequencing in Oncology: Fundamentals, Interpretation and Clinical Impact The Molecular Tumour Board will host a Live Webinar Workshop session on the 7th March 2023, 16.00-17.00. This promises to be highly informative educational meeting delivered by the resident experts of the Molecular Tumour Board as they set out to explain the practicalities and considerations around NGS testing. To register a place at this event email: MTB@cancertrials.ie CPD Approval: This event is allocated 1 CPD credit in the External CPD category by RCPI. This CPD Recognition is accepted ..read more

The Spring DSSG meetings will take place in the TCD Biomedical Sciences Building, 152 – 160 Pearse St, Dublin, D02 R590. The main meeting room will be the Tercentenary Hall. This will host the stakeholder meeting (see below) and larger DSSG meetings, while other DSSG meetings will take place in a smaller room nearby. In both cases, meetings are hybrid and attendees are welcome in-person, or virtually. DSSG meetings / Agenda The agenda for the Spring DSSG meetings is in development and will be published in due course, with MS Teams meeting links included, to enable remote attendance. DSSG mee ..read more

We are delighted to announce that MTB meetings are now accredited with CPD points awarded by the Royal College of Physicians Ireland. This is great recognition of the high educational value of the meetings and the important role they have to play in precision oncology in Ireland. The MTB continues to meet regularly on the last Tuesday of every month from 4-5pm. For further information on the MTB click here.  ..read more

At the Cancer Retreat in May, Prof Seamus O’Reilly announced a National Green Cancer Clinical Trials initiative. Global warming has become the major concern affecting us and many organisations have established green initiatives to mitigate it. Our colleagues in the laboratories are leading in this area and our Universities have Green Campus programs.  Prof O’Reilly proposed the establishment of a national initiative with representatives from all of the clinical trial units – consensus would be established on areas where progress could be made – initially in the workplace – computers ..read more